Pacemakers

This channel includes news and new technology innovations for pacemakers used to treat bradycardia.

Heart Rhythm 2022 has come to a close, and the Heart Rhythm Society has released some stats regarding this year's conference. More than 7,700+ heart rhythm professionals from around the world whose participation during Heart Rhythm 2022

Heart Rhythm 2022 Highlights

May 17, 2022 — Heart Rhythm 2022 has come to a close, and the Heart Rhythm Society has released some stats regarding ...

May 17, 2022

News | EP Lab

Late-breaking Data at ACC.22 with Over 1 Million Patients Demonstrates a Major Gap in Guideline Adherence Resulting in Higher Mortality for Patients with Infected CIEDs

Royal Philips, a global leader in health technology, announced late-breaking results of a large-scale, real-world ...

April 12, 2022

Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Aveir single-chamber (VR) leadless pacemaker for the treatment of patients in the U.S. with slow heart rhythms.

News | Pacemakers

Abbott Receives FDA Approval for Aveir VR Leadless Pacemaker System

April 5, 2022 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Aveir single-chamber ...

April 05, 2022

News | Pacemakers

'Bionic' Pacemaker Reverses Heart Failure

February 16, 2022 – A revolutionary pacemaker that re-establishes the heart’s naturally irregular beat is set to be ...

February 16, 2022

News | Pediatric Cardiology

Doctor Pioneers Pacemaker Procedure in Kids

February 15, 2022 — UC Davis pediatric electrophysiologist Dan Cortez placed two objects onto the table in front of ...

February 15, 2022

Philips, a global leader in health technology, is supporting the American Heart Association’s multi-year effort to generate awareness among cross-disciplinary specialties and improve survival rates from cardiovascular implantable electronic device (CIED) infections.

News | Implantable Cardioverter Defibrillator (ICD)

Philips supports AHA’s efforts to raise awareness of CIED infections

February 14, 2022 — Philips, a global leader in health technology, is supporting the American Heart Association’s multi ...

February 14, 2022

Feature | EP Lab

When Do Children Need Pacemakers and Defibrillators?

Children’s Hospital Los Angeles cardiologist Michael Silka, M.D., helped to pioneer the development of indications for ...

December 07, 2021

Videos | EP Lab

VIDEO: Advances in Electrophysiology Technology

Christine Albert, M.D., MPH, professor, chair of the Department of Cardiology and the Lee and Harold Kapelovitz ...

November 22, 2021

The FDA said the Medtronic Micra leadless pacemaker may have a higher rate of serious complications due to cardiac perforations during implant and is trying to get more information on these incidents.

Feature | EP Lab

FDA Warns Micra Leadless Pacing System May Have Risk of Major Complications Due to Cardiac Perforations

November 18, 2021 — The U.S. Food and Drug Administration (FDA) is reminding providers about the risk of major ...

November 18, 2021

Implicity provides a remote cardiac monitoring and research platform used by Independent Diagnostic Testing Facilities and medical centers to deliver high-quality care for patients with connected cardiac devices. On this platform, Implicity aggregates, normalizes and standardizes data from any implantable cardiac device across all manufacturers.

Feature | EP Lab | By Arnaud Rosier, M.D.

Addressing Physician Concerns About Missing CIED Patient Data

With 1.2 to 1.4 million new electrophysiology (EP) devices being prescribed to patients around the world each year ...

October 28, 2021

News | EP Lab

ESC Issues Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy

October 1, 2021 — The European Society of Cardiology (ESC) guidelines on cardiac pacing and cardiac resynchronization ...

October 04, 2021

Videos | EP Lab

VIDEO: Antibacterial Envelope for EP Devices Reduced Infections in Patients With Hemotomas by 82 Percent

Khaldoun Tarakji, M.D., MPH, associate section head, cardiac electrophysiology, Heart and Vascular Institute at ...

October 04, 2021

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death

News | Pacemakers

Boston Scientific Recalls INGENIO Family of Pacemakers

August 9, 2021 — Boston Scientific is recalling INGENIO family of pacemakers and CRT-Ps due to the risk of incorrect ...

August 09, 2021

Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1] demonstrating a significantly lower infection risk for patients who develop hematomas after cardiac implantable electronic devices (CIEDs) when the Tyrx Absorbable Antibacterial Envelope is used at implant. The analysis showed an 82% reduction in major CIED infections among patients with the Tyrx Envelope who developed hematomas compared to patients in the control group who developed hematomas.

News | EP Lab

Tyrx Absorbable Antibacterial Envelope Effectively Reduces Infections in Cardiac Device Patients with Hematomas

July 27, 2021 — Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1] demonstrating ...

July 27, 2021

In the past decade there has been a proliferation of clinical-grade wearable monitors and implantable devices such as pacemakers, ICDs, implantable cardiac monitors, and new pacemaker-like devices that can control hypertension. In the near future, these devices will be tied into a body-wide internet of things for specific patients that can transmit patient data to clinicians wirelessly to enable an integrated, more robust form of telecardiology and telemedicine.

Feature | Telecardiology | Victor Wollesen

Next Generation Cardiac Wearables and Implantables Will Integrate Into Wireless Body Area Networks

Cardiovascular diseases are among the leading causes of death for people over 65 years old in North America and Europe ...

July 23, 2021